GSK FILES

Special Thanks to Christopher Lane and Doug Bremner


PAXIL/SEROXAT - GREATEST NUMBER OF SUICIDE ATTEMPTS**NEW





**NEW
GSK Paxil Caspper Document






GlaxoSmithKline program called “Psychnet”



----

Foreword by Paul N. Jenner, Director and Vice President of Neuroscience and Strategic Product Development



----

Section 1: Towards the Second Billion -- All SSRIs Are Not the Same



----

Section 2: New Indications: Social Anxiety Disorder / Social Phobia



----

Section 3: Issues Management: Managing the Discontinuation Issue.



----

"Duration of Treatment and Depression: Relapse and Recurrence Rates"



----

"Paxil CR" Product Monograph



----

Paxil Litigation Documents



----

GSK's paxil.com... still a wealth of [dis]information

OTHER FILES/ARTICLES OF IMPORTANCE

MENATL HEALTH ADVOCATES ATTACK SEROXAT CAMPAIGNERS, LITIGANTS AND SOLICITORS

GIRLS USED AS GUINEA PIGS IN HPV TRIALS ADMITS GSK



DOCUMENT RETENTION, LETTERS TO MINISTERS, LETTERS AND EMAILS ABOUT SEROXAT AND LIST OF FOI REQUESTS



MINUTES OF MEETING BETWEEN MHRA AND BOB FIDDAMAN



PRESS RELEASE: GSK INVESTIGATION CONCLUDES



MHRA INVESTIGATION INTO GLAXOSMITHKLINE/SEROXAT



GSK SEROXAT - LETTER TO GSK FROM MHRA



GSK SEROXAT - LETTER TO TRADE ASSOCIATIONS



SUMMARY OF REGULATORY ACTION



LETTER FROM GSK CHIEF MEDICAL OFFICER TO MHRA



MHRA RESPONSE TO LETTER FROM GSK CHIEF MEDICAL OFFICER



MHRA CRITISIZED



WHO KILLED JAPANESE CULTURE?
Article By Bob Fiddaman




PAXIL STUDY 329 ALL OVER AGAIN?
Article By Bob Fiddaman

SSRi Antidepressant Drugs
Jeffrey Dach

More Seroxat related articles at http://fiddaman.blogspot.com